AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements
The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities
Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market
PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience
Biologics by McKesson, selected as a specialty pharmacy distributor for three specialty drugs recently, is starting the new year with momentum
Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients
Biologics has contracted with more than 500 payers and offers more than 150 therapies
Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs